Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.940
-0.060 (-3.00%)
At close: May 21, 2026, 4:00 PM EDT
2.079
+0.139 (7.14%)
After-hours: May 21, 2026, 7:06 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $122.91 million as of May 21, 2026. Its market cap has increased by 85.43% in one year.
Market Cap
122.91M
Enterprise Value
100.15M
1-Year Change
85.43%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $122.91M, a decrease of -76.53%. That is a compound annual growth rate of -26.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 125.71M | 75.56% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 135.01M |
| Connect Biopharma Holdings | 133.39M |
| Agenus | 131.26M |
| Genelux | 129.67M |
| Alpha Cognition | 126.29M |
| Cardiff Oncology | 122.38M |
| Kalaris Therapeutics | 117.72M |
| Alps Group | 116.48M |